Identification of the potential targets for keloid and hypertrophic scar prevention

References

• Bayat A, McGrouther D, Ferguson M. Skin scarring. BMJ. 2003;326:88.
   PubMed Web of Science ®Google Scholar
• Bell L, McAdams T, Morgan R, et al. Pruritus in burns: a descriptive study. J Burn Care Rehabil. 1988;9:305.
   PubMedGoogle Scholar
• Gras C, Ratuszny D, Hadamitzky C, et al. miR-145 contributes to hypertrophic scarring of the skin by inducing myofibroblast activity. Mol Med (Cambridge, MA). 2015;21:296.
   PubMed Web of Science ®Google Scholar
• B S. New developments in wound care. London: PJB Publications; 2000. p. 1–255.
   Google Scholar
• Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17:113.
   PubMed Web of Science ®Google Scholar
• Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol. 2004;4:583–594.
   PubMed Web of Science ®Google Scholar
• Wong VW, You F, Januszyk M, et al. Tacrolimus fails to regulate collagen expression in dermal fibroblasts. J Surg Res. 2013;184:678–690.
   PubMed Web of Science ®Google Scholar
• Cheng J, Wang Y, Wang D, et al. Identification of collagen 1 as a post-transcriptional target of miR-29b in skin fibroblasts: therapeutic implication for scar reduction. Am J Med Sci. 2013;346:98–103.
   PubMed Web of Science ®Google Scholar
• Brazma A, Parkinson H, Sarkans U, et al. ArrayExpress—a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 2003;31:68–71.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.
   PubMed Web of Science ®Google Scholar
• Oliveros JC. An interactive tool for comparing lists with Venn's diagrams; 2007–2015 [Internet]. Available from: http://bioinfogp.cnb.csic.es/tools/venny/index.html
   Google Scholar
• Huang da W, Sherman BT, Tan Q, et al. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007;8:R183.
   PubMed Web of Science ®Google Scholar
• Raney BJ, Cline MS, Rosenbloom KR, et al. ENCODE whole-genome data in the UCSC genome browser (2011 update). Nucleic Acids Res. 2011;39:D871–D875.
   PubMed Web of Science ®Google Scholar
• von Mering C, Huynen M, Jaeggi D, et al. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31:258–261.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504.
   PubMed Web of Science ®Google Scholar
• He X, Zhang J. Why do hubs tend to be essential in protein networks? PLoS Genet. 2006;2:e88.
   PubMed Web of Science ®Google Scholar
• Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Marui N, Sakai T, et al. ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. Oncogene. 1993;8:1449–1455.
   PubMed Web of Science ®Google Scholar
• Omelchenko T, Vasiliev J, Gelfand I, et al. Rho-dependent formation of epithelial “leader” cells during wound healing. Proc Natl Acad Sci. 2003;100:10788–10793.
   PubMed Web of Science ®Google Scholar
• Ridley AJ. Rho family proteins: coordinating cell responses. Trends Cell Biol. 2001;11:471–477.
   PubMed Web of Science ®Google Scholar
• Van Aelst L, Symons M. Role of Rho family GTPases in epithelial morphogenesis. Genes Dev. 2002;16:1032–1054.
   PubMed Web of Science ®Google Scholar
• Brock J, Midwinter K, Lewis J, et al. Healing of incisional wounds in the embryonic chick wing bud: characterization of the actin purse-string and demonstration of a requirement for Rho activation. J Cell Biol. 1996;135:1097–1107.
   PubMed Web of Science ®Google Scholar
• Monnier PP, Sierra A, Schwab JM, et al. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol Cell Neurosci. 2003;22:319–330.
   PubMed Web of Science ®Google Scholar
• Wang Z-Q, Ovitt C, Grigoriadis AE, et al. Bone and haematopoietic defects in mice lacking c-fos. 1992;360:741.
   Google Scholar
• Chiu R, Boyle WJ, Meek J, et al. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell. 1988;54:541–552.
   PubMed Web of Science ®Google Scholar
• Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991;1072:129–157.
   PubMed Web of Science ®Google Scholar
• Bullitt E. Expression of C-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J Comp Neurol. 1990;296:517–530.
   PubMed Web of Science ®Google Scholar
• Wilkinson D, Bhatt S, Ryseck R, et al. Tissue-specific expression of c-jun and junB during organogenesis in the mouse. Development. 1989;106:465–471.
   PubMed Web of Science ®Google Scholar
• Teofoli P, Barduagni S, Ribuffo M, et al. Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J Dermatol Sci. 1999;22:31–37.
   PubMed Web of Science ®Google Scholar
• Wu M, Melichian DS, de la Garza M, et al. Essential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing. Am J Pathol. 2009;175:1041–1055.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Chen S-J, Wu M, et al. Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma. Am J Pathol. 2008;173:1085–1099.
   PubMed Web of Science ®Google Scholar
• de Belle I, Mercola D, Adamson ED. Method for cloning in vivo targets of the Egr-1 transcription factor. Biotechniques. 2000;29:162–169.
   PubMed Web of Science ®Google Scholar
• Subbaramaiah K, Yoshimatsu K, Scherl E, et al. Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease Evidence for involvement of the transcription factor Egr-1. J Biol Chem. 2004;279:12647–12658.
   PubMed Web of Science ®Google Scholar
• Chen Z-H, Kim HP, Sciurba FC, et al. Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS ONE. 2008;3:e3316.
   PubMed Web of Science ®Google Scholar
• McCaffrey TA, Fu C, Du B, et al. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J Clin Invest. 2000;105:653.
   PubMed Web of Science ®Google Scholar
• Braddock M. The transcription factor Egr-1: a potential drug in wound healing and tissue repair. Ann Med. 2001;33:313–318.
   PubMed Web of Science ®Google Scholar
• McMahon AP, Champion J, McMahon J, et al. Developmental expression of the putative transcription factor Egr-1 suggests that Egr-1 and c-fos are coregulated in some tissues. Development. 1990;108:281–287.
   PubMed Web of Science ®Google Scholar